The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Beta-Blockers Could Cause Sleep Disturbances, But Not Linked to Depression
March 16th 2021A systematic review and meta-analysis of data from more than 280 studies is providing insight into the potential increase in risk of depression and other psychiatric adverse events associated with beta-blockers.
Cardiology's Top Advances in the 21st Century with Gregory Weiss, MD
March 1st 2021Dr. Gregory Weiss reflects on what he believes are the 6 most significant advances to occur in cardiovascular medicine since 2000. His picks included statins, public awareness campaigns, and transcatheter aortic valve replacement.
Hypertension in Pregnancy Predicts Cardiovascular Disease Risk A Decade After Birth
February 25th 2021An analysis of data from 130 women suggests those with hypertensive disorders of pregnancy were at an increased risk of cardiovascular disease later in life, even if they had no baseline history of cardiovascular disease.
Plant Protein Intake Linked to Lower Risk of All-Cause, Cardiovascular Death Among Aging Women
February 24th 2021Using data from the Women's Health Initiative, a new analysis found increased intake of plant protein was linked to lower risk of all-cause mortality, as well as deaths related to cardiovascular disease and dementia, in postmenopausal women.